*Refresh the page if the below document does not appear.
On Monday, Mankind Pharma announced the acquisition of majority stakes in Uparkarma Pharma for an undisclosed amount. The investment will allow the Ayurveda and herbal-based company to strengthen their product profile and offerings.
Akums Pharma, a leading contract manufacturing drug firm is planning to expand its business globally and increase its product range to hike its revenue to ₹10,000 Crore by 2028, as stated by the firm’s Managing Director.
Lupin Limited announced on Monday that their wholly owned subsidiary in Brazil, MedQuímica, has signed an agreement to acquire all rights to nine medicines from BL Indústria Ótica Ltda., a subsidiary of Bausch Health Companies Inc.
The drug major declared that they have received permission for import and marketing in Form CT-20 (subsequent new drug approval) from the CDSCO (Central Drugs Standard Control Organisation) for Dapagliflozin tablets of 10 mg.
Leading drug discovery company C4X Discovery Holdings plc. has signed an exclusive worldwide licensing agreement with AstraZeneca worth almost $402 million, for its NRF2 Activator program indicated oral therapy for the treatment of inflammatory and respiratory diseases.
The Maharashtra government is planning to set up a bulk drug park in Raigad district to cut the cost of manufacturing bulk drugs by creating state-of-art infrastructure facilities supported by the central government.
If you don’t already have an account click the button below to create your account.Create New Account
Please update your profile to keep using the website